Dutch join backlash at expensive drugs by making their own

8 March 2019 - In a radiation-proof room at the Erasmus Medical Center in Rotterdam, Emar Thomasa sits behind shielded glass ...

Read more →

Determining the comparative value of pharmaceutical risk-sharing policies in non–small cell lung cancer using real-world data

2 March 2019 - Risk-sharing arrangements can be used to mitigate uncertainty about the value of a drug by sharing the ...

Read more →

Pharma lashes out at the Netherlands over drug pricing policies

6 November 2019 - As the Dutch government gets more aggressive about controlling the cost of medicines, the pharmaceutical industry ...

Read more →

Novartis and Vertex battle the Netherlands government over pricing

4 February 2019 - Two large drug makers are squaring off against the Netherlands as drug pricing increasingly becomes a ...

Read more →

Big pharma firms criticise Dutch campaign to slash drug prices

5 February 2019 - Foreign pharmaceuticals companies in the Netherlands say they are ‘concerned’ that the government is undermining the ...

Read more →

Minister to ‘talk to Novartis’ after five-fold cancer drug price hike

10 January 2019 - Health minister Bruno Bruins is planning to talk to Swiss pharmaceuticals giant Novartis this week about ...

Read more →

Better together when buying medicines? Taking stock of the BeNeLuxA initiative

11 December 2018 - With Ireland being the latest to join in June 2018, there is clearly interest in the ...

Read more →

Health insurer takes pharma giant to court for ‘evergreening’

20 September 2018 - Health insurance group Menzis is taking legal action against Astra Zeneca, accusing the pharmaceuticals firm of ...

Read more →

Dutch doctors fight pharma company’s 500 fold drug price rise

3 September 2018 - Regulator urged to probe Leadiant Biosciences’ alleged abuse of market power. ...

Read more →

Using real world data in health technology assessment (HTA) practice: a comparative study of five HTA agencies

21 March 2018 - This study examines whether real world data is incorporated in health technology assessment (HTA) of melanoma drugs ...

Read more →

Drug companies are blackmailing us with expensive drugs: health care chief

19 February 2018 - The Dutch healthcare institute Zorginstituut Nederland says insurers should stop paying for expensive drugs if pharmaceutical ...

Read more →

Cystic fibrosis patients may take state to court over medicine funding

18 October 2017 - A lobby group for people suffering from cystic fibrosis is considering taking legal action against the ...

Read more →

Managed entry agreements for oncology drugs: lessons from the European experience to inform the future

4 April 2017 - The aim of this study was to conduct an analysis on the regulation and application of ...

Read more →